Recent advances in research on the mechanisms and treatment of LncRNAs in lymphoma
Long non-coding RNA (lncRNA) refers to RNA molecules exceeding 200 nucleotides in length that possess minimal protein-coding potential. These molecules play a crucial regulatory role in the initiation and progression of tumors.Lymphoma poses a significant global health burden, with substantial incidence and mortality worldwide. Although current treatment methods have demonstrated good efficacy, many cases still experience recurrence. Therefore, further in-depth exploration of its mechanism and the development of more effective targeted drugs are still necessary. In this paper, we review the fundamental principles of lncRNAs in lymphoma, outline the mechanisms by which lncRNAs influence lymphoma—including their role in regulating novel tumor cell death pathways such as ferroptosis, cuproptosis, and pyroptosis—and discuss their potential clinical applications in lymphoma. Overall, this review presents a novel approach for LncRNA-targeted therapy in lymphoma.
Authors
- Lanlan Zang (ORCID: https://orcid.org/0000-0001-7364-4876)
- Qingjun Meng (ORCID: https://orcid.org/0000-0001-6621-0017)
- Jinlian Hu
- Ruonan Li
- Hongye Ren
- Cailing Hao
- Yanan Zhao
- Haiquan Wang
- Guifen Wang
- Yu Zhang
Institutions
- Linyi People's Hospital (CN)
- Qilu Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1007/s12672-026-06311-3
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shandong Province